Independent Director · 4D Molecular Therapeutics, Inc. (FDMT)

Chair, Nominating/Governance Committee

Shawn Cline Tomasello, MBA — 4D Molecular Therapeutics Director Compensation (2025)

Fiscal year 2025 director compensation for Shawn Cline Tomasello, MBA at 4D Molecular Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 28, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Shawn Cline Tomasello, MBA’s full pay file as a PDF — free

More than this page: up to 10 years of Shawn’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Shawn Cline Tomasello, MBA and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

4D Molecular Therapeutics Director Compensation Table · all 4 fiscal years held
In US dollars, as 4D Molecular Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$62,500$0$70,000$0$132,500
FY2024$61,944—$417,236$0$479,180
FY2023$57,500—$287,624$0$345,124
FY2021$52,500—$419,391$0$471,891

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: 4D Molecular Therapeutics, Inc. DEF 14A filed April 28, 2026, accession 0001140361-26-017427, and prior-year filings. Open the filing on EDGAR.

How this page was built: the 4D Molecular Therapeutics, Inc. filed document, accession 0001140361-26-017427. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2026.

Get the 4D Molecular Therapeutics Board Governance Report

$132,500 Shawn Cline Tomasello, MBA, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 28, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

4D Molecular Therapeutics pays directors a $40,000 cash retainer and $70,000 in Options.

Committees

FY2025 · as the proxy prints them

Compensation · Nominating/Governance (Chair) · Science and Technology

The rest of the 4D Molecular Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Charles Theuer, M.D., Ph.DIndependent Director$135,000
David Kirn, M.DDirector—
Glenn SblendorioIndependent Director—
Jacob Chacko, M.D., MBAIndependent Director$135,000
John F. Milligan, Ph.DChair of the Board$255,000
Nancy Miller-RichIndependent Director$122,500
Susannah Gray, MBAIndependent Director$135,000

The full 4D Molecular Therapeutics compensation record

free company brief

This page is one director within 4D Molecular Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Order FDMT

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report